SynthesisHuman vaccines & immunotherapeutics2016
Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.
Synthesis in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed.
- Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh.Science (New York, N.Y.) · 2022Trial
- Trial
- Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women.Human vaccines & immunotherapeutics · 2019Trial
- Behavioral intention to perform risk compensation behaviors after receiving HPV vaccination among men who have sex with men in China.Human vaccines & immunotherapeutics · 2019Trial
- HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination.AIDS and behavior · 2018Trial
- Healthcare providers' beliefs and attitudes regarding risk compensation following HPV vaccination.Papillomavirus research (Amsterdam, Netherlands) · 2016Trial
- Projected public health benefits of a hypothetical HSV-1 vaccine in the United States: A mathematical modeling analysis.Science advances · 2026Article
- Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy.Communications medicine · 2026Article
- Using the HPV vaccine as a public health case study for identifying potential barriers to a Fentanyl vaccine.Harm reduction journal · 2026Article
- Political Ideology and HPV Vaccine Awareness: Sex Differences and Nursing Implications Using the Health Information National Trends Survey (HINTS).Nursing research and practice · 2026Article
- Effect of human papillomavirus (HPV) vaccine on HPV type replacement and sexual behaviors in the post-vaccine era: A cross-sectional study.Human vaccines & immunotherapeutics · 2025Article
- A content analysis of religion and HPV vaccine news coverage in Canada.Human vaccines & immunotherapeutics · 2025Article
- Influences on Emergency Clinician Use of Health Information Exchange: Interview Study.JMIR medical informatics · 2025Article
- Human papillomavirus awareness in a digital world: The intersection of faith and online media.Preventive medicine reports · 2025Article
- If It Were Enabling, Where's the Evidence? Applying Moral Hazard and Risk Compensation Theories to Community Naloxone Distribution and Other "Safety Net" Public Health Interventions.Journal of studies on alcohol and drugs · 2025Article
- Vaccination as a strategy for Chlamydia trachomatis control: a global mathematical modeling analysis.BMC global and public health · 2025Article
- Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.Viruses · 2024Review
- Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses.BMJ public health · 2024Article
- Human papillomavirus vaccination at the first opportunity: An overview.Human vaccines & immunotherapeutics · 2023Review
- COVID-19 vaccination and changes in preventive behaviours: findings from the 2021 vaccine roll-out in Switzerland.European journal of public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
There has been some concern among parents and in the media that vaccinating children against human papillomavirus could be seen as giving children permission to engage in risky sexual behaviors (also known as sexual disinhibition). Several studies have found this concern to be unfounded but there have been no attempts to synthesize the relevant studies in order to assess if there is evidence of sexual disinhibition. The aim of this study was to synthesize recent literature examining sexual behaviors and biological outcomes (e.g., sexually transmitted infections) post-HPV vaccination. We reviewed literature from January 1, 2008-June 30, 2015 using PubMed, CINAHL, and Embase with the following search terms: [(sex behavior OR sex behavior OR sexual) AND (human papillomavirus OR HPV) AND (vaccines OR vaccine OR vaccination)] followed by a cited reference search. We included studies that examined biological outcomes and reported behaviors post-vaccination in both males and females. Studies were reviewed by title and abstract and relevant studies were examined as full-text articles. We identified 2,503 articles and 20 were eventually included in the review. None of the studies of sexual behaviors and/or biological outcomes found evidence of riskier behaviors or higher rates of STIs after HPV vaccination. Instead, the studies found that vaccinated compared to unvaccinated individuals were less likely to report vaginal intercourse without a condom (OR = 0.5; 95%CI = 0.4-0.6) and non-use of contraception (OR = 0.27; 95%CI = 0.15-0.48) and unvaccinated participants had higher rates of Chlamydia (OR = 2.3; 95%CI = 1.06-5.00). These results should be reassuring to parents and health care providers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.